Discounted Cash Flow (DCF) Analysis Unlevered

Palisade Bio, Inc. (PALI)

$0.408

+0.01 (+1.49%)
All numbers are in Millions, Currency in USD
Stock DCF: 1.87 | 0.408 | undervalue

Operating Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 0.260.020.010.01000000
Revenue (%)
EBITDA -4.73-8.49-10.12-44.28-15.15-3.73-1.75-0.82-0.38-0.18
EBITDA (%)
EBIT -4.92-8.63-10.12-44.28-15.15-3.74-1.75-0.82-0.38-0.18
EBIT (%)
Depreciation 0.190.1400000000
Depreciation (%)

Balance Sheet Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 5.795.110.7110.4912.381.740.810.380.180.08
Total Cash (%)
Account Receivables 0.360.020.060.151.440.140.070.030.010.01
Account Receivables (%)
Inventories ---2.23-0.15-1.44-0.31-0.15-0.07-0.03-0.02
Inventories (%)
Accounts Payable 0.830.823.551.521.830.330.150.070.030.02
Accounts Payable (%)
Capital Expenditure -0-0-0-0-0-0-0-0-0-0
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 0.408
Beta 1.575
Diluted Shares Outstanding 0.88
Cost of Debt
Tax Rate 10.25
After-tax Cost of Debt 3.73%
Risk-Free Rate
Market Risk Premium
Cost of Equity 11.593
Total Debt 0.40
Total Equity 0.36
Total Capital 0.76
Debt Weighting 52.94
Equity Weighting 47.06
Wacc

Build Up Free Cash

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 0.260.020.010.01000000
EBITDA -4.73-8.49-10.12-44.28-15.15-3.73-1.75-0.82-0.38-0.18
EBIT -4.92-8.63-10.12-44.28-15.15-3.74-1.75-0.82-0.38-0.18
Tax Rate 0.00%0.00%-2.40%-2.46%10.25%1.08%1.08%1.08%1.08%1.08%
EBIAT -4.92-8.63-10.37-45.37-13.60-3.70-1.73-0.81-0.38-0.18
Depreciation 0.190.1400000000
Accounts Receivable -0.34-0.04-0.09-1.291.290.080.040.020.01
Inventories ----2.081.29-1.13-0.17-0.08-0.04-0.02
Accounts Payable --0.012.73-2.040.31-1.50-0.17-0.08-0.04-0.02
Capital Expenditure -0-0-0.01-0-0.01-0-0-0-0-0
UFCF -4.73-8.16-7.67-49.58-13.29-5.03-1.99-0.93-0.44-0.21
WACC
PV UFCF -53.26-13.29-4.68-1.73-0.75-0.33-0.14
SUM PV UFCF -7.63

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 7.43
Free cash flow (t + 1) -0.21
Terminal Value -3.86
Present Value of Terminal Value -2.70

Intrinsic Value

Enterprise Value -10.33
Net Debt -11.98
Equity Value 1.65
Shares Outstanding 0.88
Equity Value Per Share 1.87